Dr Agarwals Eye Hospital Limited

NSE: DRAGARWQ · Unclassified

₹5,380.00-0.29%06 Nov 2026

Ask the data

Instant answers about Dr Agarwals Eye Hospital Limited — computed from its filings, no language model

Market cap₹2,529 cr

Current price₹5,380.00

High / Low₹5,423 / ₹4,788

P/E33.2

P/B—

Book value—

ROE—

ROCE—

Debt / equity—

Dividend yield—

EPS (TTM)₹162.17

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 18 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†	FY20†	FY21†	FY22†	FY23†	FY24†	FY25†	FY26†
Revenue	72.8	88.0	102.8	103.5	108.3	112.7	118.2	136.6	148.5	153.3	170.1	175.9	139.8	201.2	267.9	317.5	397.1	470.9
EBITDA	9.2	10.3	12.5	10.8	11.9	10.5	12.8	14.1	21.5	23.4	28.9	46.2	30.4	57.7	74.7	89.2	118.5	145.3
Operating margin	12.7%	11.7%	12.2%	10.5%	11.0%	9.3%	10.9%	10.3%	14.5%	15.3%	17.0%	26.3%	21.7%	28.7%	27.9%	28.1%	29.8%	30.9%
Interest	3.6	4.0	4.0	4.4	3.5	3.5	3.2	3.7	3.3	2.6	2.6	7.7	6.3	6.2	6.9	7.2	13.4	11.9
Depreciation	5.5	6.3	6.4	5.7	5.4	6.1	6.2	11.4	8.7	9.8	10.9	21.2	19.1	20.4	20.2	26.6	39.5	45.6
Profit before tax	0.6	1.0	3.6	2.9	4.4	3.7	5.4	-0.5	9.8	13.4	17.4	19.9	5.7	32.3	49.4	62.2	70.7	93.6
Tax	0.4	0.5	1.6	1.3	1.3	1.3	-0.3	-0.5	3.2	6.6	5.5	6.3	7.2	8.2	12.5	15.9	16.1	23.5
Net profit	0.2	0.5	2.0	1.6	3.1	2.4	5.7	0.0	6.6	6.8	11.9	13.7	-1.4	24.1	36.9	46.4	54.6	70.1

Quarterly performance

last 76 quarters · ₹ crore

showing latest 8 of 76 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†	SEP '19†	DEC '19†	MAR '20†	JUN '20†	SEP '20†	DEC '20†	MAR '21†	JUN '21†	SEP '21†	DEC '21†	MAR '22†	JUN '22†	SEP '22†	DEC '22†	MAR '23†	JUN '23†	SEP '23†	DEC '23†	MAR '24†	JUN '24†	SEP '24†	DEC '24†	MAR '25†	JUN '25†	SEP '25†	DEC '25†	MAR '26†	JUN '26†
Revenue	8.7	10.8	12.9	15.6	18.0	18.8	20.5	21.5	21.7	20.8	23.9	26.4	25.4	23.5	27.4	27.3	25.9	24.1	26.1	27.2	28.0	25.3	27.7	28.3	28.3	28.1	27.9	29.4	30.1	28.6	30.0	36.0	36.7	28.5	35.3	38.4	39.3	34.1	36.7	41.8	39.3	34.6	37.6	44.4	44.0	40.7	41.0	46.5	45.5	43.6	40.3	15.0	30.3	42.7	51.7	30.9	58.2	56.5	55.7	66.4	68.8	63.5	69.2	77.8	83.3	75.7	80.7	100.0	102.2	95.1	99.8	116.9	117.7	116.2	120.0	143.0
Operating profit	1.4	-1.4	2.5	1.4	0.4	3.0	4.4	2.2	2.0	0.7	5.5	4.4	2.9	1.6	3.6	4.3	2.1	1.7	2.8	3.5	2.0	2.8	3.7	2.7	2.7	2.2	2.9	3.9	3.6	2.2	3.2	4.7	4.4	0.5	4.5	5.4	5.5	2.5	8.1	9.9	8.9	0.3	4.4	9.7	8.7	4.1	6.4	13.7	12.3	9.9	10.3	-4.2	6.1	12.7	15.8	5.2	19.3	16.8	16.4	19.8	18.6	15.3	20.9	21.9	22.4	20.5	24.4	31.4	29.9	25.6	31.6	37.1	40.1	34.4	33.7	43.3
Operating margin	16.5%	-13.0%	19.4%	8.9%	2.1%	16.2%	21.6%	10.2%	9.2%	3.1%	22.9%	16.6%	11.5%	6.8%	13.2%	15.7%	8.1%	7.1%	10.5%	12.7%	7.1%	11.0%	13.3%	9.5%	9.7%	7.8%	10.3%	13.2%	11.8%	7.8%	10.6%	13.1%	11.9%	1.8%	12.6%	14.1%	14.1%	7.2%	22.1%	23.6%	22.6%	0.8%	11.8%	21.9%	19.8%	10.0%	15.7%	29.3%	27.1%	22.8%	25.6%	-28.1%	20.0%	29.6%	30.6%	16.8%	33.2%	29.8%	29.4%	29.8%	27.1%	24.2%	30.2%	28.1%	26.9%	27.1%	30.3%	31.4%	29.2%	26.9%	31.6%	31.8%	34.0%	29.6%	28.1%	30.3%
Other income	0.2	0.5	0.1	0.0	0.1	0.1	0.3	0.3	0.2	0.2	0.2	0.1	0.4	0.6	0.4	0.3	0.8	0.5	0.6	0.5	0.1	0.4	0.5	0.7	0.7	0.4	1.0	0.4	0.2	0.2	1.2	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.5	0.9	0.7	0.4	0.3	0.6	0.6	0.4	0.3	0.3	1.6	0.3	0.1	0.0	0.4	0.3	0.4	0.2	0.3	0.2	0.8	0.2	0.6	1.1	2.3	0.9	2.5	0.4	2.3	2.3	0.1	0.8	0.7	2.8	1.6	2.0
Interest	0.3	0.5	0.4	0.7	0.9	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	1.0	1.0	1.1	1.1	1.1	1.0	0.9	0.8	0.8	0.8	0.9	0.9	0.8	0.8	0.8	0.8	0.8	0.9	0.9	1.0	0.9	0.9	0.8	0.8	0.7	0.5	0.5	0.6	1.0	0.5	0.7	0.6	0.9	1.8	2.3	1.7	1.9	1.4	1.7	1.6	1.7	1.4	1.5	1.5	1.7	2.2	1.1	1.7	1.8	1.6	1.7	1.8	2.0	3.0	3.7	3.9	2.9	4.2	3.7	2.0	2.0	2.8
Depreciation	0.7	0.9	1.2	1.1	1.2	1.4	1.8	1.4	1.5	1.6	1.8	1.5	1.6	1.6	1.6	1.4	1.5	1.6	1.3	1.2	1.4	1.2	1.5	1.2	1.4	1.6	1.9	1.0	1.0	1.0	3.2	4.6	1.9	2.2	2.6	1.9	2.0	2.1	2.7	2.1	2.5	2.7	2.4	2.3	2.4	2.8	3.5	5.5	4.9	5.2	5.7	4.9	4.5	4.9	4.8	5.0	5.0	4.7	5.7	5.7	5.8	7.1	1.5	5.8	6.3	6.9	7.5	9.9	9.4	10.0	10.2	10.6	11.3	11.7	12.1	11.5
Profit before tax	0.7	-2.4	1.0	-0.3	-1.7	0.7	2.0	0.1	-0.2	-1.8	2.9	2.0	0.7	-0.5	1.3	2.1	0.3	-0.5	1.0	1.8	-0.2	1.1	1.8	1.3	1.2	0.1	1.1	2.4	2.0	0.6	0.3	-0.4	1.6	-2.7	1.1	2.6	3.0	-0.4	4.6	7.4	6.3	-2.0	1.7	7.4	6.0	1.4	2.7	6.8	5.5	3.4	4.3	-10.3	0.0	6.1	9.8	-1.0	13.2	10.9	9.2	12.1	12.4	6.7	18.2	15.5	16.6	12.7	17.3	18.9	19.1	14.1	18.6	23.2	25.7	23.4	21.2	31.0
Tax	0.4	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	-0.1	0.5	0.8	0.3	0.0	0.4	0.8	0.0	0.1	0.4	0.1	0.2	0.0	0.9	0.1	0.1	0.0	1.0	0.6	0.5	0.2	-1.6	-0.6	0.7	-0.9	0.3	0.9	1.0	-0.1	1.5	2.6	2.2	-0.7	2.6	2.2	2.0	0.2	1.1	2.0	2.3	0.9	1.1	-2.6	0.0	1.7	8.1	-0.2	3.4	2.7	2.4	3.0	3.3	1.6	4.5	4.0	4.1	3.3	4.5	4.8	5.0	3.7	2.6	5.9	6.4	6.2	5.0	7.6
Net profit	0.3	-2.4	0.7	-0.4	-1.8	0.6	1.7	0.0	-0.2	-1.7	2.5	1.2	0.4	-0.5	0.9	1.3	0.3	-0.6	0.6	1.6	-0.4	1.1	0.9	1.2	1.0	0.1	0.1	1.8	1.5	0.4	1.9	0.1	0.9	-1.8	0.8	1.7	2.0	-0.3	3.1	4.8	4.1	-1.3	-0.8	5.2	4.0	1.1	1.6	4.8	3.2	2.4	3.2	-7.6	-0.0	4.4	1.8	-0.7	9.8	8.2	6.9	9.1	9.1	5.1	13.7	11.5	12.6	9.4	12.8	14.1	14.2	10.4	16.0	17.3	19.3	17.3	16.2	23.4
EPS ₹	0.63	—	1.43	—	—	1.40	3.81	0.07	—	—	5.48	2.69	0.86	-1.05	2.05	2.87	0.76	-1.40	1.32	3.57	-0.93	2.39	1.95	2.68	2.20	0.27	0.13	3.91	3.23	0.89	4.09	0.30	1.94	-3.79	1.63	3.68	4.26	-0.60	6.64	10.29	8.72	-2.83	-1.77	11.13	8.46	2.44	3.32	10.25	6.79	5.19	6.88	-16.19	-0.03	9.43	3.73	-1.54	20.86	17.34	14.63	19.38	19.30	10.77	29.11	24.55	26.79	20.09	27.21	30.02	30.11	22.13	0.00	0.00	0.00	0.00	0.00	0.00
Revenue YoY	—	—	—	—	107.0%	73.4%	58.1%	38.2%	20.6%	10.8%	16.8%	23.1%	16.6%	13.0%	14.6%	3.4%	2.3%	2.5%	-4.7%	-0.6%	8.1%	4.9%	6.2%	4.2%	1.0%	11.1%	0.5%	3.9%	6.2%	1.8%	7.6%	22.4%	22.1%	-0.5%	17.7%	6.5%	7.1%	19.9%	3.9%	9.0%	-0.1%	1.3%	2.4%	6.1%	11.8%	17.5%	9.2%	4.8%	3.6%	7.2%	-1.8%	-67.7%	-33.4%	-1.9%	28.3%	105.5%	91.8%	32.1%	7.6%	115.1%	18.1%	12.5%	24.3%	17.2%	21.1%	19.1%	16.6%	28.6%	22.7%	25.7%	23.7%	16.9%	15.2%	22.2%	20.2%	22.3%
Profit YoY	—	—	—	—	-728.6%	—	163.1%	—	—	-373.0%	44.4%	3933.3%	—	—	-62.8%	6.6%	-12.8%	—	-35.9%	24.8%	-223.5%	—	49.2%	-24.8%	—	-87.9%	-93.2%	52.1%	47.6%	223.1%	3100.0%	-92.4%	-40.1%	-523.8%	-59.9%	1135.7%	119.8%	—	305.2%	179.8%	105.0%	—	-126.6%	8.1%	-2.9%	—	—	-7.8%	-19.8%	112.2%	107.7%	-257.9%	-100.3%	81.6%	-46.0%	—	—	84.0%	292.6%	—	-7.4%	-37.9%	99.1%	26.7%	38.8%	86.6%	-6.5%	22.3%	12.4%	10.2%	25.0%	22.3%	36.5%	66.2%	1.6%	35.5%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 73 periods

	JUN '08	SEP '08	DEC '08	MAR '09	JUN '09	SEP '09	DEC '09	MAR '10	JUN '10	SEP '10	DEC '10	MAR '11	JUN '11	SEP '11	DEC '11	MAR '12	JUN '12	SEP '12	DEC '12	MAR '13	JUN '13	SEP '13	DEC '13	MAR '14	JUN '14	SEP '14	DEC '14	MAR '15	JUN '15	SEP '15	DEC '15	MAR '16	JUN '16	SEP '16	DEC '16	MAR '17	JUN '17	SEP '17	DEC '17	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Net margin	-3.8%	-6.7%	-1.3%	0.3%	0.8%	2.6%	-0.3%	0.6%	1.8%	2.4%	3.6%	2.0%	2.1%	2.0%	1.8%	1.5%	1.8%	1.1%	2.7%	2.9%	2.5%	3.8%	2.9%	2.2%	2.7%	3.1%	3.3%	4.8%	3.2%	2.6%	0.9%	0.0%	1.2%	1.9%	2.9%	4.4%	6.4%	7.8%	7.0%	4.4%	4.6%	4.4%	5.7%	7.0%	6.7%	6.2%	6.8%	7.8%	0.9%	-1.5%	0.0%	-1.0%	3.5%	8.3%	9.6%	12.0%	14.3%	13.4%	11.8%	13.8%	14.1%	14.6%	15.4%	14.6%	14.4%	14.1%	13.6%	13.8%	14.0%	14.7%	15.5%	14.9%	15.3%
EBITDA margin	8.2%	5.0%	11.2%	12.7%	12.7%	14.1%	11.0%	11.7%	13.5%	13.9%	14.5%	12.2%	12.0%	11.1%	11.2%	10.5%	9.7%	9.4%	10.3%	11.0%	10.2%	10.8%	10.1%	9.3%	10.3%	10.8%	10.8%	10.9%	11.0%	11.0%	9.7%	10.3%	10.6%	11.2%	12.1%	14.5%	17.1%	19.3%	17.8%	15.3%	14.9%	14.4%	16.2%	17.0%	19.1%	21.0%	24.0%	26.3%	19.6%	17.1%	19.3%	21.7%	25.6%	28.9%	29.0%	28.7%	30.5%	29.0%	27.6%	27.9%	27.5%	27.4%	28.0%	28.1%	29.1%	29.6%	29.5%	29.8%	30.0%	31.3%	31.8%	30.9%	30.5%
Interest coverage	0.46	-0.33	0.87	1.17	1.27	1.63	1.01	1.25	1.74	2.00	2.32	1.91	1.92	1.79	1.76	1.67	1.58	1.50	1.95	2.25	2.19	2.59	2.29	2.08	2.41	2.71	2.91	2.67	1.76	1.60	0.66	0.87	1.67	2.08	2.81	4.00	6.04	7.86	7.84	6.14	6.26	5.91	7.18	7.75	5.35	3.96	3.75	3.59	1.39	0.62	1.03	1.90	3.34	5.49	6.34	6.19	7.52	7.78	6.96	8.19	9.37	9.32	10.08	9.68	8.65	7.45	6.52	6.26	6.15	6.58	8.10	8.88	10.66

Balance sheet

equity vs borrowings over time · ₹ crore

Not filed yet.

Cash flow

annual · ₹ crore · line = free cash flow

Not filed yet.

Where the assets sit

No balance sheet filed yet.

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Dr Agarwals Eye Hospital Limited	2,529	5,380.00	33.2	—	—

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+3.5%

6 months+6.1%

1 year—

3Y CAGR—

5Y CAGR—

10Y CAGR—

50-day avg₹5,226.66

200-day avg—

RSI (14)63

FAQs

What is the share price of Dr Agarwals Eye Hospital Limited?

Dr Agarwals Eye Hospital Limited (DRAGARWQ) closed at ₹5,380.00 on NSE on 06 Nov 2026.

What is the market cap of Dr Agarwals Eye Hospital Limited?

₹2,529 crore at the latest close.

What is the P/E ratio of Dr Agarwals Eye Hospital Limited?

33.2, on trailing-twelve-month earnings from its filings.

How fast is Dr Agarwals Eye Hospital Limited growing?

Dr Agarwals Eye Hospital Limited: revenue has compounded at 20.7% a year over three years; net profit at 23.8% a year. Latest-quarter revenue is up 22.3% year on year, profit up 35.5%.

How profitable is Dr Agarwals Eye Hospital Limited?

On a trailing-twelve-month basis operating margin 30.5%, net margin 15.3%.

How much debt does Dr Agarwals Eye Hospital Limited have?

Debt to equity isn't meaningful for Dr Agarwals Eye Hospital Limited (banks borrow as part of their business) or isn't filed yet.

Dr Agarwals Eye Hospital Limited's results are not in NSE's XBRL filings, so these are its standalone quarterly results as published on BSE (†), ₹ crore, from SEP '07; full years are summed from the quarters. No balance sheet or cash flow is available from this source. Information only, not investment advice.